1. P613 Comparative objective effectiveness of vedolizumab and ustekinumab in a real-life cohort of active Crohn's disease patients failure to TNF inhibitors. (21st January 2022) Authors: Onali, S; Pugliese, D; Caprioli, F A; Orlando, A; Biancone, L; Nardone, O M; Imperatore, N; Fiorino, G; Cappello, M; Viola, A; Principi, M B; Bezzio, C; Aratari, A; Carparelli, S; Mazzuoli, S; Manguso, F; Grossi, L; Bodini, G; Ribaldone, D; Mocci, G Journal: Journal of Crohn's and colitis Issue: Volume 16(2022)Supplement 1 Page Start: i542 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. P690 Comparative efficacy of vedolizumab and adalimumab as second-line therapy in ulcerative colitis patients previously treated with infliximab. (25th January 2019) Authors: Favale, A; Onali, S; Caprioli, F; Pugliese, D; Armuzzi, A; Macaluso, F S; Orlando, A; Viola, A; Fries, W; Mocci, G; Chicco, F; Usai, P; Rispo, A; Castiglione, F; Calabrese, E; Biancone, L; Monteleone, G; Fantini, M C Journal: Journal of Crohn's and colitis Issue: Volume 13(2019)Supplement 1 Page Start: S465 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗